Discovery of 1-(β-amino substituted-β-alanyl)-N,N-dimethylindoline-2-carboxamides as novel nonpeptide antagonists of nociceptin/orphanin FQ receptor: Efficient design, synthesis, and structure–activity relationship studies
作者:Shigeo Hayashi、Katsuyo Ohashi、Eriko Nakata、Chie Emoto
DOI:10.1016/j.ejmech.2012.07.021
日期:2012.9
Since the discovery of endogenous nociceptin/orphanin FQ (N/OFQ) peptide and N/OFQ peptide (NOP) receptor [or opioid-receptor-like-1 (ORL1) receptor], the structures, distribution, and pharmacology have been reported in detail. N/OFQ and NOP receptor are located in the corticolimbic regions that are involved in the integration of the emotional activity, and located in the spinal cord, the peripheral
自从发现内源性伤害感受器/孤儿蛋白FQ(N / OFQ)肽和N / OFQ肽(NOP)受体[或阿片受体样1(ORL1)受体]以来,已经报道了其结构,分布和药理学细节。N / OFQ和NOP受体位于参与情绪活动整合的皮层区,并位于脊髓,周围神经系统或其他与疼痛以及尿液信号传递相关的周围组织中,其模式不同于啮齿动物或灵长类动物中的经典阿片肽及其受体。此外,N / OFQ-NOP受体系统在各种人类生理机能的调节中起着重要作用,例如抑郁症效应,食欲亢进效应和血压效应。在这项研究中,N,N-二甲基二氢吲哚-2-羧酰胺在体外进行了研究,以阐明鉴定和开发有效和选择性NOP受体拮抗剂的结构要求,从而发现了1- 3- [4-(取代苯基)哌啶-1-基]酰基]丙酰基} -N,N-二甲基二氢吲哚-2-羧酰胺类似物,其显示有效的和选择性的人NOP(hNOP)受体结合亲和力和有效的hNOP受体拮抗剂活性。有效和选择